KINPEYGO

This brand name is authorized in Austria, Estonia, France, Croatia, Ireland, Italy, Lithuania, Romania

Active ingredients

The drug KINPEYGO contains one active pharmaceutical ingredient (API):

1 Budesonide UNII Q3OKS62Q6X - BUDESONIDE

Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers. Read about Budesonide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
KINPEYGO Modified-release hard capsule	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A07EA06	Budesonide	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07E Intestinal antiinflammatory agents → A07EA Corticosteroids acting locally
Discover more medicines within A07EA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1896521, 1896532
Country: FR	Base de données publique des médicaments	Identifier(s): 69799026
Country: IT	Agenzia del Farmaco	Identifier(s): 050226012, 050226024
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1095099, 1096002
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69385001, W69385002